ADORA2A and neoplasm: Hence inhibition of CD73, A2AR or CD38 in combination with anti-PD-1, has been shown to elicit enhanced anti-tumour T cell responses mediated by enhanced IFNγ and Granzyme B expression by CD8+ T cells [131,204,205].